Live feed
Filing
SC 13G
SC 13G0001610520-24-000023·ASLAN Pharmaceuticals Ltd
Schedule 13G ownership disclosure
ASLAN PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 04522R200
Event date: 2023-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 16,917,600
- Percent of class
- 8.9100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001610520-24-000023
- Form type
- SC 13G
- Filer
- ASLAN Pharmaceuticals Ltd
- CIK
- CIK 1722926
- Filed
- Feb 06, 2024
- Reporting period
- Dec 29, 2023
- Description
- Schedule 13G beneficial ownership